Amazon, Omada partner on digital health benefits program: We unpack the tech giant’s latest healthcare endeavor and explore how Amazon can help digital health companies enroll more members.
Digital health venture funding fell back to 2019 levels: And things aren’t looking up for companies that are running out of cash. Expect a lot more M&A or shutdowns in 2024.
Mayo Clinic forges more deals to improve AI models: It signed deals with Cerebras Systems and TruLite Health to build foundational AI models. The results could build more trust in the tech among healthcare organizations.
Eli Lilly debuts D2C website for Rx access: We examine the drugmaker’s ambitions and explore how it will impact patients and other pharma players.
Employers need tools to assess employees’ health risks: HeartRisk is a new tool that employers can use to gauge their workforce’s risk of heart disease. It’s just one of many preventive care solutions employers are seeking in 2024.
More healthcare providers and insurers are revealing prices: Almost 91% of hospitals posted some prices for services and procedures in 2023. The federal gov’t is continuing to push for even more transparency in 2024.
Pharma still loves traditional TV ads, even as audiences tune out: Drug advertisers spent $4.37 billion on TV ads in 2023 and will likely spend more in 2024. But even older adults are turning to digital channels.
Digital health startups to watch: We spotlight insurtech Devoted Health and metabolic disease platform Twin Health on the back of fresh funding.
Swoop’s predictive AI enables pharma marketers to target even undiagnosed patients: It’s the latest example of how AI models are helping pharma brands reach more patients and providers.
Peloton is the latest to try out TikTok’s brand hubs: The fitness company is the second major brand to try TikTok’s innovative ad format after Disney in October.
Weight loss drugs work, but adherence rates are a mixed bag: Marketers know the better a product works, the longer consumers will use it. But less than half of adults were still taking these meds after three months. We dig into more research findings.
Patients’ pixel-tracking lawsuits hit hospitals: Meta’s Pixel tracker allegedly sent sensitive health information to social media platforms. Patients sued, and hospitals are paying up—both parties are losers.
Doctors’ presence on Zocdoc matters: Providers must enhance their online profiles and more effectively market their offerings to consumers—particularly as medical bookings skyrocket in the New Year.
Class action lawsuits against healthcare insurers bear watching: Humana and United Healthcare are accused of using AI predictive tools to automate claim denials, despite a high error rate. The cases could lead to greater scrutiny of how AI is deployed by all insurers in decision-making support.
An unprecedented ITC ruling based on claims that Apple infringed on blood oxygen monitoring patents leaves the tech giant no recourse but to temporarily pull its devices.
Consumer trust in genAI for health info comes down to familiarity: We explore why two recent patient-focused surveys on genAI reveal stark differences.
Americans are in worse physical shape than ever: Obesity and diabetes have reached record highs, and healthy eating habits are “substantially” worse than before the pandemic. At least we’re still exercising as much—or as little—as we did in 2019.
Our most-read healthcare stories of 2023: Stories that got our readers most excited to read in the past year include health information on social media, genAI, pharma’s move to digital, and generational healthcare marketing.
These are the healthcare startups that raised the most cash in 2023: We take a look back at which digital health companies and which market segments investors bet most on this past year,
How Cost Plus Drugs is shaking up the PBM landscape: We unpack the pharmacy startup’s disruptive moves in 2023 and how they’re impacting insurers, employers, and conventional PBMs.